Diarrhea management in children under five in sub-Saharan Africa: does the source of care matter? A Countdown

Liliana Carvajal-Vélez1, Agbessi Amouzou2, Jamie Perin3

  • 1United Nations Children's Fund UNICEF, 3 UN Plaza, New York City, NY, 10017, USA. liliana.carvajal.a@gmail.com.

BMC Public Health
|August 20, 2016
PubMed

Insights

Childhood diarrhea management is often poor in sub-Saharan Africa, even in health facilities. Improving care quality at both community and facility levels is crucial for saving young lives.

Area of Science:

  • Pediatrics
  • Global Health
  • Public Health Policy

Background:

  • Diarrhea is a leading cause of death in children under five globally, accounting for 9% of mortality.
  • Effective diarrhea management practices are critical for reducing child mortality in high-burden regions.

Purpose of the Study:

  • To analyze diarrhea management practices in young children in sub-Saharan Africa.
  • To assess the association between the quality of diarrhea management and the source of care utilized.

Main Methods:

  • Utilized Demographic and Health Survey data from 12 sub-Saharan African countries.
  • Classified diarrhea management quality as good, fair, or poor based on WHO/UNICEF guidelines.
  • Assessed associations between management quality and care source, adjusting for confounders.

Main Results:

  • Good diarrhea management prevalence was low (17-38%) in 11 of 12 countries, with Sierra Leone being an exception (67%).
  • Even children seeking care at health facilities showed limited good management practices (median 52%).
  • Care from health facilities or community providers was linked to better management than informal/traditional sources or no care; facility vs. community provider effectiveness varied by country.

Conclusions:

  • Inadequate diarrhea care for children persists in high-burden sub-Saharan African countries, including within healthcare facilities.
  • Significant improvements in careseeking and quality of care are urgently needed at both community and facility levels.
  • Saving children's lives requires immediate, focused efforts on optimizing diarrhea management strategies.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
522
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
836
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1000
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
573